Details for New Drug Application (NDA): 204266
✉ Email this page to a colleague
The generic ingredient in DEXMETHYLPHENIDATE HYDROCHLORIDE is dexmethylphenidate hydrochloride. There are six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the dexmethylphenidate hydrochloride profile page.
Summary for 204266
Tradename: | DEXMETHYLPHENIDATE HYDROCHLORIDE |
Applicant: | Aurolife Pharma Llc |
Ingredient: | dexmethylphenidate hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 204266
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 5MG | ||||
Approval Date: | Aug 25, 2015 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
Approval Date: | Aug 25, 2015 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 15MG | ||||
Approval Date: | Aug 25, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription